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Thousands	die	each	year	from	sudden	infant	death	syndrome	(SIDS).	Neither	the	cause	nor	basis	for	varied	
prevalence	in	different	populations	is	understood.	While	2	cases	have	been	associated	with	mutations	in	type	Va,	
cardiac	voltage-gated	sodium	channels	(SCN5A),	the	“Back	to	Sleep”	campaign	has	decreased	SIDS	prevalence,	
consistent	with	a	role	for	environmental	influences	in	disease	pathogenesis.	Here	we	studied	SCN5A	in	African	
Americans.	Three	of	133	SIDS	cases	were	homozygous	for	the	variant	S1103Y.	Among	controls,	120	of	1,056	were	
carriers	of	the	heterozygous	genotype,	which	was	previously	associated	with	increased	risk	for	arrhythmia	in	
adults.	This	suggests	that	infants	with	2	copies	of	S1103Y	have	a	24-fold	increased	risk	for	SIDS.	Variant	Y1103	
channels	were	found	to	operate	normally	under	baseline	conditions	in	vitro.	As	risk	factors	for	SIDS	include	
apnea	and	respiratory	acidosis,	Y1103	and	wild-type	channels	were	subjected	to	lowered	intracellular	pH.	Only	
Y1103	channels	gained	abnormal	function,	demonstrating	late	reopenings	suppressible	by	the	drug	mexiletine.	
The	variant	appeared	to	confer	susceptibility	to	acidosis-induced	arrhythmia,	a	gene-environment	interaction.	
Overall,	homozygous	and	rare	heterozygous	SCN5A	missense	variants	were	found	in	approximately	5%	of	cases.	
If	our	findings	are	replicated,	prospective	genetic	testing	of	SIDS	cases	and	screening	with	counseling	for	at-risk	
families	warrant	consideration.
Introduction
Sudden infant death syndrome (SIDS) is the leading cause of infant 
mortality in the US among all racial and ethnic groups, represent-
ing nearly one-third of deaths between 1 month and 1 year of age 
(1). These losses continue despite dramatic improvement with the 
1994 launch of the “Back to Sleep” campaign discouraging prone 
sleep for infants, a known risk factor for SIDS (2) that indicates a 
role for environmental stressors in the disorder. SIDS is defined as 
sudden and unanticipated death in an infant with no recognized 
lethal disorder after an investigation that includes autopsy, exami-
nation of the death scene, and review of the history (3). Suggesting 
a role for genetic predisposition, there is significant variation in 
SIDS among racial and ethnic groups; rates for African Americans 
and Native Americans are 3 times those for whites and 6 times 
higher than for Hispanics and Asians (1).
While multiple recognized risk factors suggest that SIDS is 
more than 1 entity and its pathogenesis multifactorial, the car-
diac hypothesis (4, 5) has regained support due to identification in 
postmortem genetic samples from SIDS cases of mutations in the 
same ion channel genes that cause inherited and acquired long QT 
syndrome (LQTS) (6–11), 1 in a potassium channel (12) and 2 in 
a sodium channel (13). In addition to SIDS and LQTS, mutations 
in SCN5A cause Brugada syndrome, sudden unexplained noctur-
nal death syndrome (14), idiopathic ventricular fibrillation (15), 
congenital sick sinus syndrome (16), and progressive cardiac con-
duction defect (Lenegre-Lev disease) (17). Of note, many of these 
disorders are associated with bradycardia, the only consistent pre-
morbid arrhythmia seen on cardiopulmonary monitors in SIDS 
cases immediately prior to death (18). Most SCN5A mutations 
causing arrhythmia produce channels that continue to operate late 
in the cardiac cycle when normal channels are silent; such late activ-
ity is a substrate for chaotic rhythms and sudden death (19–21). 
In African Americans, the common missense variant SCN5A 
S1103Y confers an 8-fold increased risk of arrhythmia without 
marked change in channel function in vitro (22). Genetic modula-
tion of risk by exposure to extrinsic factors is seen in patients who 
carry potassium channel variants that are well tolerated until drug 
exposure produces arrhythmia (10, 11) and is consistent with a 
multi-hit pathogenesis for cardiac arrhythmia (23). To investigate 
the impact of changes in cardiac ion channel function on the risk 
of SIDS, samples were screened for genetic variations in SCN5A, 
and the attributes of variant channels were studied in the presence 
and absence of stressors and antiarrhythmic medications.
Results
Cohort and genetic analysis. The 224 autopsy-confirmed cases of SIDS 
in our case-control study reflect the expected distribution of SIDS 
cases in the US based on sex and ethnicity, with higher numbers 
of African Americans than whites (African American, 133; white, 
86) and males than females (male, 106; female, 79). The control 
population for the African American SIDS cases consisted of 1,056 
African American adults without known health problems. Twen-
ty of the 133 African American SIDS cases had SCN5A variants 
that changed the channel protein (Supplemental Tables 1 and 2; 
Nonstandard	abbreviations	used: LQTS, long QT syndrome; SCN5A, voltage-gated 
sodium channel, type Va; SIDS, sudden infant death syndrome; V1/2, voltage depen-
dence of steady-state inactivation.
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supplemental material available online with this article; 
doi:10.1172/JCI25618DS1). Thirteen cases were heterozygous for 
a common variant where a C replaces A in the second position of 
codon 1103 on 1 copy of SCN5A to yield a change from serine to 
tyrosine in the channel (Figure 1), indicating the genotype S1103/
Y1103 (SY). Three cases (2 female, 1 male) were homozygous for 
the variant genotype Y1103/Y1103 (YY), and so these infants car-
ried only Y1103 channels. Four other cases had rare variants that 
changed a residue elsewhere in the channel on 1 SCN5A allele (Sup-
plemental Figure 1). Of the 1,056 African American adult controls, 
the wild-type genotype S1103/S1103 (SS) was observed 935 times, 
SY was seen 120 times (similar to the previously reported frequen-
cy; refs. 22, 24), and 1 individual was homozygous (YY). This last 
individual could not be relocated to investigate for evidence of 
family history of SIDS or cardiac rhythm disturbances; he was 40 
years of age and healthy at the time of sample collection.
Hardy-Weinberg equilibrium. Observed and expected genotypic 
frequencies, assuming Hardy-Weinberg equilibrium (HWE), for 
each genotype in African Americans were as follows. In SIDS cases 
(n = 133): SS 117, 115 expected; SY 13, 17.6 expected; YY 3, 0.68 
expected. In controls (n = 1,056): SS 935, 938 expected; SY 120, 
115 expected; YY 1, 3.52 expected. Case genotype frequencies were 
not in HWE (c2 = 9.21; P = 0.002), whereas control frequencies did 
not significantly deviate from HWE (c2 = 2.04; P = 0.15). In SIDS 
cases, there was a 4-fold excess of YY genotypes over the expected 
amount. In the controls, there was 1 YY individual, whereas 3 or 4 
were expected. Comparing YY frequency in SIDS cases with con-
trols, 3 of 133 (2.3%) versus 1 of 1,056 (0.1%), gives an odds ratio 
for SIDS of 24.4 (95% confidence interval, 1.9 to 1,279), indicating 
an approximately 24-fold increase in risk with the YY genotype. 
Overrepresentation of YY in SIDS cases was statistically signifi-
cant, with a P value of 0.005 by Fisher’s exact test. To rule out mis-
attribution in SIDS cases identified as African American, all SIDS 
cases with SY and YY genotypes were evaluated and confirmed to 
bear the expected genetic ancestral proportions for Americans of 
African descent and were unrelated (Supplemental Table 1 and 
Supplemental Figure 2).
Y1103 channels inactivate abnormally at low pH. SCN5A encodes a 
2016 residue a subunit with 4 similar domains (Figure 1B, DI–DIV) 
that fold in pseudosymmetric fashion to form a single, central 
ion permeation pathway lined by 4 pore loops. Position 1103 is in 
the intracellular linker between DII and DIII. To investigate chan-
nel operation, wild-type S1103 or Y1103 channel a subunits were 
expressed with the β subunit of SCN5A, SCN1B, in mammalian tis-
sue culture cells (HEK-293) (25). Channels were first studied using 
whole-cell patch-clamp mode so currents passed by many channels 
were assessed simultaneously. At pH 7.4, S1103 and Y1103 chan-
nels were found to function indistinguishably, showing the same 
midpoint for voltage-dependent activation (Figure 2A), midpoint 
for voltage-dependent steady-state inactivation (Figure 2B), and 
time course for recovery from inactivation (Figure 2C). Splawski 
and colleagues (22) observed subtle changes in gating of Y1103 
channels under baseline conditions that were not apparent in our 
system. Hypothesizing that a more significant change in channel 
function might result from a challenge experienced in vivo, we 
assessed the effect of acidosis.
Because neither residue is charged, an amino acid change from S 
to Y is not expected to produce pH sensitivity a priori. Nonetheless, 
lowering cytosolic pH (from 7.4 to 7.0 and 6.7) was found to induce 
progressive shifts in the voltage dependence of steady-state inactiva-
tion (V1/2) for Y1103 channels (Figure 2, bottom row); thus, Y1103 
showed V1/2 to equal –88 ± 1, –84 ± 2, and –77 ± 2 mV at pH 7.4, 7.0, 
and 6.7, respectively (n = 4–8). Wild-type S1103 channels did not 
show a similar change (V1/2 = –87 ± 2, –88 ± 1, and –84 ± 1 mV at pH 
7.4, 7.0, and 6.7, respectively; n = 7–21) and so significantly differed 
with Y1103 at pH 6.7 (P = 0.005). In contrast, external acidification 
is expected to block peak current and shift steady-state inactiva-
tion (27), and these effects were observed for both channels to the 
same degree (Supplemental Table 3). Internal acidification was also 
found to speed recovery from inactivation of Y1103 but not wild-
type SCN5A channels (Figure 2, bottom row). Changing the inter-
nal solution to pH 6.7 led to a small decrease in recovery time for 
Y1103 channels that reached statistical significance (P < 0.05; n = 11 
for each condition). Internal acidification also induced a small shift 
in the current/voltage relationship for Y1103 (Figure 2A, bottom 
inset) that did not achieve statistical significance.
These findings suggest Y1103 channels exposed to low internal 
pH might operate at times during the cardiac cycle when wild-
type channels remain silent. To assess this hypothesis, whole-cell 
currents were recorded from groups of cells expressing S1103 
channels with internal pH 7.4 or 6.7 (Figure 3, A and B; n = 10 
Figure 1
A polymorphism in SCN5A encodes a variant cardiac sodium channel. 
(A) Denaturing HPLC waveform and direct sequencing of wild-type 
and S1103Y variant. The chromatogram shows the additional peak 
resulting from heteroduplex assembly of S1103 and Y1103 amplicons. 
Forward sequence of homozygous S1103 and Y1103 SIDS cases 
shows the C3308A change that leads to the substitution of serine (S) 
by tyrosine (Y). (B) Topology of the cardiac sodium channel encoded 
by SCN5A shows the cytoplasmic location of the S1103Y missense 
change (red), the 4 homologous membrane domains (DI–DIV), the 
pore-forming (P) loops, and the voltage-sensing segments (+).
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cells for each condition). As expected, currents rapidly activated 
and inactivated to baseline; a double exponential fit revealed 
time constants of 1.8 ± 0.04 and 2.0 ± 1.8 ms and 1.9 ± 0.01 and 
1.8 ± 0.8 ms at normal and low pH, respectively. Conversely, Y1103 
channels produced sustained whole-cell currents at low internal 
pH that did not return to baseline and showed altered inactiva-
tion kinetics (Figure 3, A and B). Late current was 5.23% ± 0.85% 
of peak, and time constants were 2.5 ± 0.01 and 1.9 ± 3.4 ms and 
2.6 ± 0.01 and 79 ± 0.6 ms at normal and low pH, respectively 
(n = 10 cells, 50 sweeps/cell).
These changes in the voltage dependence of steady-state inactiva-
tion (11 mV) and sustained current (5%) with lowered pH were com-
parable to 2–6 mV shifts and 1–3% sustained currents previously 
reported for SCN5A-dependent arrhythmia by others (22, 28, 29). 
To confirm that late currents observed with low internal pH were 
carried by SCN5A rather than by other channel, transport, or leak 
pathways, single-channel function was studied.
Single Y1103 channels show abnormal late reopenings. Single wild-
type cardiac sodium channels are closed at rest, open briefly with 
membrane depolarization, and then rapidly inactivate, staying 
silent despite maintained depolarization; the 
channels stay inactivated until the membrane 
repolarizes to resting potential, at which point 
they return to the closed state in preparation for 
the next heartbeat. A shift in the voltage depen-
dence of inactivation with low pH suggests 
that single Y1103 channels may be active after 
depolarization, when wild-type channels are 
inactivated. As expected, single wild-type S1103 
channels in inside-out patches opened just once 
on depolarization and then remained inactive at 
both pH 7.4 and pH 6.7 (Figure 4A); conversely, 
Y1103 channels operated normally at pH 7.4 but 
showed abnormal reopenings during depolar-
ization at pH 6.7. Repetitive cycles of stimula-
tion of single channels averaged in cumulative 
fashion revealed that both the Y1103 change 
and low internal pH were required to induce 
sustained (late) current (Figure 4B).
Mexiletine suppresses pathological late reopenings. 
Bennett and colleagues demonstrated that 
SCN5A mutations associated with familial LQTS 
type 3 produce late channel reopenings with-
out application of external stressors (8). These 
reopenings are blocked 5–10 times more effec-
tively than initial openings (i.e., those required 
for normal cardiac function) by the channel 
blocker mexiletine, an antiarrhythmic used in 
adults and children (30). To assess drug suppres-
sion of Y1103 channels, a repetitive activation 
protocol approximating a heart rate of 150 bpm 
was used (sodium channel block is sensitive 
to rate due to altered drug affinity in closed, 
open, and inactivated states). First, block of 
initial (peak) currents in whole-cell mode at 
pH 7.4 and 6.7 was studied. At pH 7.4, S1103 and 
Y1103 channels were inhibited similarly by pro-
pranolol and amiodarone (Supplemental Table 4), 
whereas Y1103 channels were somewhat more 
sensitive to mexiletine (Figure 5A, S1103 
K1/2 = 23.2 ± 1.1 µM [where K1/2 is the drug concentration yield-
ing half maximal blockade], Y1103 K1/2 = 13.7 ± 1.3 µM; n = 8). 
At pH 6.7, peak currents of Y1103 channels similarly remained 
sensitive to blockade (K1/2 = 16.2 ± 1.2 µM; n = 8). To assess block 
of abnormal late reopenings, single Y1103 channels were studied 
at pH 6.7. As expected, application of 5 µM mexiletine produced 
no significant suppression of initial activation (the null trace 
frequency was unaltered; Figure 5B), while nearly complete sup-
pression of pathological late activity seen in the absence of drug 
(Figure 4B) was achieved (Figure 5B).
Discussion
The SCN5A Y1103 allele has been associated with arrhythmia 
and sudden death in 3 situations. African Americans with 
a single copy of the allele show an 8-fold increase in risk for 
arrhythmia as they reach middle age (22). Three siblings in a 
white kindred carrying a single allele have syncope, ventricu-
lar tachycardia, ventricular fibrillation, and sudden death (31). 
Here, homozygous African Americans infants carrying 2 Y1103 
alleles showed a 24-fold increased risk for SIDS, with SIDS 
Figure 2
Y1103 channels show a change in inactivation gating at low pH. Whole-cell currents 
in HEK-293 cells expressing SCN5A S1103 (open squares) or SCN5A Y1103 (filled 
squares). Top: Sample traces with S1103 channels. Arrows indicate points of measure. 
Scale bar: 1 nA. Filter and sampling frequencies were 5 and 20 kHz, respectively. (A) 
Normalized conductance/voltage (G/Gmax) relationships for S1103 and Y1103 channels 
show no change with a shift of internal pH (pHi) from pH 7.4 to pH 6.7 (n = 4–13). Curves 
fitted to a Boltzmann relationship (y = 1/{1 + exp[V – V1/2/Vs]}, where Vs is slope factor). 
Inset: Current/voltage relationships. Values for V1/2 are reported in Supplemental Table 
3. (B) Y1103 channels showed a shift in voltage-dependent steady-state inactivation at 
pHi 6.7, whereas S1103 channels did not. Normalized peak current values (I/Imax) are 
plotted against prepulse potential (mV). Curves fitted as in A. At pH 6.7, V1/2 for S1103 is 
–84 + 1 mV (n = 7) and for Y1103 is –77 + 2 mV (n = 8; P < 0.05; 2-population Student’s 
t test). Values are mean ± SEM. (C) Time constants for recovery from inactivation were 
the same for S1103 and Y1103 channels at physiological pH but were speeded when 
Y1103, but not S1103, was exposed to pHi 6.7 (n = 11). Curves are exponential fits to 
the recovery time course, I(t)/Imax = Af[1 – exp(–t/τf)] + As[1 – exp(–t/τs)], where A is the 
amplitude of fast (f) and slow (s) components and t is time. Values for τ are reported in 
Supplemental Table 3.
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cases out of HWE. We hypothesize that the allele is a substrate 
for cardiac QT interval prolongation and ventricular arrhyth-
mia in the setting of a secondary challenge that is tolerated 
by infants with wild-type channels. We previously proposed 
a similar mechanism to mediate some cases of drug-induced 
arrhythmia where variant ion channel activity or was mark-
edly increased or did not come to light until the stress of drug 
action (10, 11). In the case of Y1103 sodium channels, acidosis 
was seen to produce gain-of-function late reopenings, abnor-
mal behavior associated with dangerous arrhythmia in patients 
with familial LQTS due to SCN5A mutations. The operation 
of Y1103 channels under baseline conditions was normal; this 
suggests that homozygous S1103Y infants will have a normal 
electrocardiogram in the absence of stressors and that this test 
would therefore not identify these genetically at-risk infants. 
Lastly, while the present report focuses on SCN5A S1103Y, the 
multifactorial nature of SIDS argues for mutation screening of 
other cardiac and noncardiac genes.
In this context, it is notable that many of the known risk fac-
tors for SIDS are stressors that can lead to prolonged apnea and 
respiratory acidosis — a common event in normal infants that 
may be exacerbated by diminished respiratory drive in situations 
including sleep, respiratory infection, multiple siblings (increas-
ing infectious exposures), premature birth, and exposure to sec-
ondhand cigarette smoke. We speculate that increased risk for 
arrhythmia in aging African Americans with the Y1103 allele (22) 
may result from a similar mechanism, that is, low intracellular 
pH due to metabolic acidosis in poorly perfused cardiac muscle 
fed by an atherosclerotic coronary bed. Importantly, the internal 
pH levels of 7.0 and 6.7 used here to challenge Y1103 channels 
in vitro are relevant to cardiac physiology. While normal arterial 
pH is approximately 7.4, intracellular pH of cardiac myocytes 
is much lower. Cardiomyocytes in anesthetized, ventilated rats, 
rabbits, dogs, sheep, and ferrets have internal pH levels between 
6.9 and 7.1 at baseline (32, 33). Internal pH decreases to 6.6–6.8 
with respiratory acidosis and/or hypoxia (34, 35). Furthermore, 
acid loads dissipate slowly in myocardium, suggesting that basal 
microheterogeneity in intracellular pH will be pronounced 
under stress (32, 36).
It should be noted explicitly that suppression of abnormal 
function of Y1103 channels in vitro does not indicate in vivo 
effectiveness and that therapy with antiarrhythmic medica-
tion carries risk; conversely, mexiletine shortens the QT inter-
val in animal models and adults with LQTS type 3 (37), and 2 
infants with LQTS type 3 have been treated with mexiletine and 
shown both tolerance of therapy and shortened QT (38, 39). 
These studies and our results suggest a strategy for prophylac-
tic therapy, that is, use of state-dependent blockers that target 
late reopenings. The results do not indicate that mexiletine 
should be administered to YY infants to prevent SIDS at the 
present time. Should future work support our conclusion that 
YY infants are at significant risk, a study of prophylactic ther-
apy is first required to assess benefits and risks. Moreover, it is 
important to note that the composition and environment of 
the channels we studied in cultured cells only approximate car-
diac cells from SIDS patients; indeed, the identity of accessory 
Figure 3
Cells expressing Y1103 channels show sustained current at a low pHi. 
Whole-cell currents were recorded in HEK-293 cells expressing S1103 
or Y1103 channels as indicated with pipette and bath solutions (see 
Methods) with cells held at –100 mV and stepped to –30 mV for 100 ms 
at a rate of 0.5 Hz. Scale bars represent 300 pA and 20 ms. (A) Repre-
sentative currents recorded from cells at the indicated pHi. (B) Ensem-
ble averages of 500 sweeps recorded from 10 cells with the indicated 
channel and pHi. Late current was 5.23% ± 0.85% of peak (n = 10 cells). 
Peak currents were not significantly different and were –1311 ± 143 pA 
and 1252 ± 139 pA, for S1103 at normal and low pH, respectively, and 
1267 ± 173 pA and 1195 ± 245 pA for Y1103 at normal and low pH, 
respectively (n = 10 cells per condition).
Figure 4
Single Y1103 channels show abnormal late reopenings. Single chan-
nels studied in inside-out, off-cell patches excised from HEK-293 cells. 
Currents were stimulated every 2.5 seconds by a 50-ms depolarizing 
pulse to –30 mV from a holding potential of –120 mV. Data were record-
ed at filter and sampling frequencies of 5 and 50 kHz, respectively. 
Pipettes were filled with bath solution described in Methods. Cells were 
perfused with the pipette solution described in Methods. For each cell, 
null sweeps (with no channel activity) were identified, averaged offline, 
and subtracted from data sweeps before analysis. For display purposes, 
data were refiltered offline using a 2-kHz Bessel filter. (A) With depolar-
ization, single S1103 channels opened, inactivated rapidly, and did not 
reopen. This behavior was unaltered when internal pH was lowered from 
7.4 to 6.7. Null traces at pH 7.4 and 6.7 were 50% ± 2.7% (n = 15 patch-
es, 1,367 sweeps) and 51% ± 3.4% (n = 12 patches, 1,028 sweeps), 
respectively. In contrast, Y1103 channels behaved like S1103 chan-
nels at pH 7.4 but showed late reopenings at pH 6.7. Null traces were 
51% ± 4.5% at pH 7.4 (n = 8 patches, 742 sweeps) and 51.7 ± 2.5% 
(n = 10 patches, 942 sweeps) when pH was reduced to 6.7. (B) Ensem-
ble average traces (n = 100–150 sweeps) for the indicated channels 
and conditions. Y1103 channels failed to remain in the inactivated state 
when exposed to internal pH 6.7. Scale bars: 0.5 pA; 10 ms.
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subunits in human sodium channels are still a subject requiring 
investigation (see ref. 40).
As with any association study, our findings will be need to be 
replicated in a separate cohort of African Americans. Even in rel-
atively homogeneous genetic isolates, population stratification 
remains a potential explanation for false positive associations 
(41). However, the allele has been associated with cardiac arrhyth-
mia in adults (22), and changes in function we observed here with 
low pH provide support for a plausible disease mechanism. The 
frequency of SIDS associated with changes in SCN5A channels 
in African Americans in our cohort was approximately 5%. Thus, 
7 of 133 SIDS cases were homozygous for YY or heterozygous 
for other residue changes in SCN5A channels. Changes at sites 
other than 1103 altered channel function at normal pH (S524Y, 
2 cases; R689H and E1107K, 1 case each; Q. Liu and S.A.N. Gold-
stein, unpublished observations). Like individuals with inher-
ited LQTS type 3, these infants had SCN5A gain in function in 
a single mutant allele. In contrast, African Americans homozy-
gous for Y1103 were at increased risk for SIDS despite channels 
that appeared to be normal at baseline. The apparent etiology is 
arrhythmia due to a secondary challenge that is tolerated by oth-
ers, perhaps respiratory acidosis due to hypoventilation. Genetic 
modulation of risk on exposure to common, extrinsic factors is 
recognized in patients who develop drug-induced arrhythmia 
due to mutations in potassium channels that are revealed upon 
drug exposure (10, 11) and is consistent with a multi-hit patho-
genesis for cardiac arrhythmia (23).
This study leads us to consider genetic screening in African 
Americans for SCN5A S1103Y in at least 3 situations: infants 
with acute life-threatening events, siblings of SIDS victims, and 
couples that experience infertility or fetal demise (42). Given the 
apparent increased risk, a comprehensive study of postmortem 
molecular analysis of approximately 2,000 SIDS cases (the num-
ber reported each year in the US) is recommended. If replicat-
ed, prospective screening in a large cohort of African American 
infants should be considered. Finally, it is imperative to contin-
ue to support effective public health efforts to decrease known 
environmental risk factors (e.g., prone sleeping position). SIDS is 
argued by this work to result, like many common disorders, from 
a genetic predisposition that yields poor tolerance of common 
challenges to physiological homeostasis.
Methods
SIDS probands. Approval for human study protocols was obtained from the 
Human Investigations Committee of Yale University. Postmortem tissue was 
collected from 224 unrelated SIDS cases from 1985 to 1992. Medical infor-
mation was limited to sex, ethnicity, age at death, time of autopsy, and a brief 
history. Neither parental DNA nor family history were available. While cases 
were diagnosed as SIDS, it is not certain that all infants in our cohort died of 
SIDS because it is a diagnosis of exclusion with no definitive test. Apparently 
healthy adult African Americans served as controls; they were not screened 
for a family history of sudden death or SIDS.
Genomic DNA preparation, amplification, and mutational analysis. Genomic 
DNA was extracted from frozen heart, brain, or kidney blocks (∼1 cm3). Tis-
sue was macerated on ice, and DNA was harvested by phenol/chloroform 
extraction, ethanol precipitation, and suspension in Tris-EDTA. The cod-
ing regions of SCN5A were amplified using primers and PCR conditions as 
shown in Supplemental Table 5. Denaturing HPLC heteroduplex analysis 
(WAVE; Transgenomic Corp.) was performed in the presence or absence of 
wild-type DNA, and variant samples were directly sequenced. For SCN5A 
S1103Y, all African American SIDS cases and controls were both screened 
by denaturing HPLC and directly sequenced. S1103Y was previously called 
S1102Y by Splawski et al. (22), whereas current mutation nomenclature for 
SCN5A now uses the long isoform NM_198056.1 (43).
Electrophysiology. Y1103 was introduced into SCN5A (NM_198056.1), 
the less abundant and longer isoform (43) carried in pcDNA1, using 
Pfu (Stratagene). Constructs were transiently cotransfected with GFP-
tagged SCN1B (the β subunit of cardiac SCN5A channel, isoform b; NM_
001037) in HEK-293 cells using lipofectamine (Invitrogen Corp.). After 
24–60 hours, whole-cell recording was performed using a 200B amplifier 
and pCLAMP software (version 8.0; Axon Instruments). Voltage errors 
were minimized using 80% series resistance compensation. Whole-cell 
recording was performed using internal (pipette) and bath solutions, 
as previously described (22): internal, 60 mM CsCl, 80 mM CsF, 10 mM 
EGTA, 1 mM CaCl2, 1 mM MgCl2, 5 mM Na2ATP, and 10 mM HEPES 
(pH adjusted to indicate levels with CsOH); bath, 130 mM NaCl, 5 mM 
CsCl, 2 mM CaCl2, 1.2 mM MgCl2, 10 mM HEPES, and 5 mM glucose 
(pH 7.4 with NaOH). Inside-out patch recording was performed using 
the same solutions, with the internal solution in the bath and the bath 
solution in the pipette. Mexiletine, propranolol, and amiodarone were 
from Sigma-Aldrich. Stock solutions were made in bath solution (mexi-
letine) or dimethyl sulfoxide (propranolol and amiodarone). Single 
channels were recorded in inside-out excised patches using borosilicate 
pipettes (Clark) coated with Sylgard (Dow Corning). All experiments 
were performed between 20–22°C.
Statistics. In addition to estimation of odds ratios and exact 95% con-
fidence limits, P values were computed using Fisher’s exact test, with a 
Figure 5
Abnormal reopenings are suppressed by mexiletine. Single channels 
were studied in inside-out, off-cell patches as in Figure 3. (A) Dose-
response curves for phasic block by mexiletine of peak macroscopic 
currents with S1103 (open squares) and Y1103 (filled squares) chan-
nels studied in whole-cell mode. Each point shows the average percent 
reduction in peak current by the dose indicated after a series of repetitive 
depolarizing stimuli (n = 3–7 cells). Cells were depolarized to –30 mV 
from a holding potential of –100 mV for 10 ms at 2.5 Hz to mimic a 
rate of 150 bpm. Inset: Representative S1103 current traces evoked 
by a pulse in drug-free solution (control) and the first (pulse 1) to 
show tonic block and fiftieth (pulse 50) to show phasic block by 10 µM 
mexiletine (mex). Values for tonic and phasic block by mexiletine, pro-
pranolol, and amiodarone are reported in Supplemental Table 4. (B) 
Single Y1103 channels studied in inside-out off-cell patches showed 
that late reopenings of variant channels were fully suppressed by 5 µM 
mexiletine. Null traces in the absence of drug (see Figure 3B) at pH 7.4 
and 6.7 were 51% ± 4.5% (n = 8 patches, 742 sweeps) and 52 ± 2.5% 
(n = 10 patches, 942 sweeps), respectively; null traces at pH 6.7 with 
drug were 55% ± 3.5% (n = 6 patches, 561 sweeps). The therapeutic 
blood level of mexiletine is 0.8–2.0 µg/ml (3.7–9.3 µM). Scale bars: 
2 ms, 200 pA (A); 0.3 pA, 10 ms (B).
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P value less than 0.05 being considered statistically significant. HWE 
predictions were reported as expected versus observed for SIDS cases 
and controls using EpiInfo 2000 software (version 1.1.2; http://www.cdc.
gov/epiinfo/). Electrophysiology data are reported as mean ± SEM with 
ANOVA unless otherwise noted.
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